Latest News about bluebird bio Inc
Recent news which mentions bluebird bio Inc
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
February 21, 2025
From CNBC.com News
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
February 18, 2025
From CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
From CNBC.com News
New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
February 23, 2024
From CNBC.com News
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
December 07, 2023
From CNBC.com News
Stocks making the biggest moves midday: Dollar General, Salesforce, C3.ai, Chewy & more
June 01, 2023
From CNBC.com News
Stocks making the biggest moves in the premarket: AutoZone, Take-Two Interactive, bluebird bio and more
September 19, 2022
From CNBC.com News
From CNBC.com News